Provided by Tiger Trade Technology Pte. Ltd.

Rocket Pharmaceuticals, Inc.

3.70
+0.16504.67%
Volume:410.72K
Turnover:1.50M
Market Cap:405.62M
PE:-21.74
High:3.71
Open:3.54
Low:3.54
Close:3.53
52wk High:5.45
52wk Low:2.53
Shares:109.77M
Float Shares:84.96M
Volume Ratio:1.52
T/O Rate:0.48%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1700
EPS(LYR):-2.0100
ROE:-4.77%
ROA:-28.42%
PB:1.10
PE(LYR):-1.84

Loading ...

PRV reception could net Rocket $100M-$200M, says LifeSci Capital

TIPRANKS
·
Mar 28

Rocket Pharmaceuticals stock weakness unwarranted, says Wedbush

TIPRANKS
·
Mar 28

BUZZ-U.S. STOCKS ON THE MOVE-Entergy, IDEX Corp, Quanta Services

Reuters
·
Mar 27

Rocket Pharmaceuticals Shares Reverse Premarket Gains, Last Down 10%

THOMSON REUTERS
·
Mar 27

Rocket Pharma Exec Says Co in Active Discussions and Engaging With External Parties Regarding the Sale of the Priority Review Voucher

THOMSON REUTERS
·
Mar 27

Rocket Pharma Exec Says Co Has Been Engaging With Payers to Ensure Reimbursement Ahead of Launch - Conf Call

THOMSON REUTERS
·
Mar 27

Rocket Pharma Exec Says Co Anticipates Commercial Availability of Kresladi in Q4 of 2026 - Exec Says

THOMSON REUTERS
·
Mar 27

Rocket Pharmaceuticals Shares up 10.2% Premarket After US FDA Approve Co's Therapy for Deadly Childhood Disorder

THOMSON REUTERS
·
Mar 27

Top Premarket Gainers

MT Newswires Live
·
Mar 27

Rocket Pharmaceuticals gains FDA accelerated approval for KRESLADI in severe pediatric LAD-I; FDA grants rare pediatric disease priority review voucher

Reuters
·
Mar 27

Rocket Pharmaceuticals Announces FDA Approval of Kresladi™ for Pediatric Patients With Severe Leukocyte Adhesion Deficiency-I (Lad-I)

THOMSON REUTERS
·
Mar 27

Rocket Pharmaceuticals announces 2026 annual stockholders meeting

Reuters
·
Mar 25

Rocket Pharma Advances BAG3 Heart Disease Study, Bolstering Long-Term Gene Therapy Story

TIPRANKS
·
Mar 21

Rocket Pharmaceuticals Inc - Enters Sales Agreement With Cantor Fitzgerald & Co. for Atm Offering up to $100 Mln - SEC Filing

THOMSON REUTERS
·
Mar 11

Rocket Pharmaceuticals signs equity distribution deal for USD 100 million at-the-market offering

Reuters
·
Mar 11

Rocket Pharmaceuticals Inc Files for Mixed Shelf of up to $400 Mln - SEC Filing

THOMSON REUTERS
·
Mar 03

Rocket Pharmaceuticals price target raised to $3 from $2 at Goldman Sachs

TIPRANKS
·
Mar 02

Chardan Capital Sticks to Its Buy Rating for Rocket Pharmaceuticals (RCKT)

TIPRANKS
·
Feb 28

Rocket Pharmaceuticals Is Maintained at Overweight by Cantor Fitzgerald

Dow Jones
·
Feb 27

Cantor Fitzgerald Reaffirms Their Buy Rating on Rocket Pharmaceuticals (RCKT)

TIPRANKS
·
Feb 27